Glioblastoma multiforme is the most common and deadliest form of brain cancer. Glioblastomas are infiltrated by a high number of microglia, which promote tumor growth and surrounding tissue invasion. However, it is unclear how microglia and glioma cells physically interact and if there are differences, depending on glioma cell type. Hence, we have developed a novel live imaging assay to study microglia–glioma interactions in vivo in the zebrafish brain. We transplanted well-established human glioblastoma cell lines, U87 and U251, into transgenic zebrafish lines with labelled macrophages/microglia. Our confocal live imaging results show distinct interactions between microglia and U87, as well as U251 glioblastoma cells that differ in number and nature. Importantly these interactions do not appear to be antitumoral as zebrafish microglia do not engulf and phagocytose the human glioblastoma cells. Finally, xenotransplants into the irf8−/− zebrafish mutant that lacks microglia, as well as pharmacological inhibition of the CSF-1 receptor (CSF-1R) on microglia, confirm a prominent role for zebrafish microglia in promoting human glioblastoma cell growth. This new model will be an important tool for drug screening and the development of future immunotherapeutics targeting microglia within glioma.
Get full access to this article
View all access options for this article.
References
1.
HollandEC. Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA, 2000; 97:6242–6244.
2.
OstromQT, GittlemanH, LiaoP, RouseC, ChenY, DowlingJ, et al.CBTRUS Statistical Report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol, 2014; 16(suppl 4):iv1–iv63.
3.
AgnihotriS, BurrellKE, WolfA, JalaliS, HawkinsC, RutkaJT, et al.Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch Immunol Ther Exp, 2012; 61:25–41.
4.
PopovaSN, BergqvistM, DimbergA, EdqvistP-H, EkmanS, HesselagerG, et al.Subtyping of gliomas of various WHO grades by the application of immunohistochemistry. Histopathology, 2013; 64:365–379.
5.
SchererHJ. A critical review: the pathology of cerebral gliomas. J Neurol Psychiatry, 1940; 3:147–177.
6.
BadieB, SchartnerJ. Role of microglia in glioma biology. Microsc Res Tech, 2001; 54:106–113.
7.
GraeberMB, ScheithauerBW, KreutzbergGW. Microglia in brain tumors. Glia, 2002; 40:252–259.
8.
PlattenM, KretzA, NaumannU, AulwurmS, EgashiraK, IsenmannS, et al.Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol, 2003; 54:388–392.
Carvalho da FonsecaAC, BadieB. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies. Clin Dev Immunol, 2013; 2013:1–5.
11.
WuA, WeiJ, KongLY, WangY, PriebeW, QiaoW, et al.Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol, 2010; 12:1113–1125.
12.
WangH, ZhangL, ZhangIY, ChenX, Carvalho da FonsecaAC, WuS, et al.S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages. Clin Cancer Res, 2013; 19:3764–3775.
13.
Ellert-MiklaszewskaA, DabrowskiM, LipkoM, SliwaM, MaleszewskaM, KaminskaB. Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Glia, 2013; 61:1178–1190.
14.
ZhangJ, SarkarS, CuaR, ZhouY, HaderW, YongVW. A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis. Carcinogenesis, 2012; 33:312–319.
15.
MarkovicDS, GlassR, SynowitzM, RooijenNV, KettenmannH. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol, 2005; 64:754–762.
16.
LiW, GraeberMB. The molecular profile of microglia under the influence of glioma. Neuro Oncol, 2012; 14:958–978.
17.
YangI, HanSJ, KaurG, CraneC, ParsaAT. The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci, 2010; 17:6–10.
CasanoAM, PeriF. Microglia: multitasking specialists of the brain. Dev Cell, 2015; 32:469–477.
20.
DavalosD, GrutzendlerJ, YangG, KimJV, ZuoY, JungS, et al.ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci, 2005; 8:752–758.
21.
HaynesSE, HollopeterG, YangG, KurpiusD, DaileyME, GanW-B, et al.The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci, 2006; 9:1512–1519.
22.
NeumannH, KotterMR, FranklinRJM. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain, 2009; 132(Pt 2):288–295.
23.
SiegerD, MoritzC, ZiegenhalsT, PrykhozhijS, PeriF. Long-range Ca2+ waves transmit brain-damage signals to microglia. Dev Cell, 2012; 22:1138–1148.
KomoharaY, OhnishiK, KuratsuJ, TakeyaM. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol, 2008; 216:15–24.
26.
PyonteckSM, AkkariL, SchuhmacherAJ, BowmanRL, SevenichL, QuailDF, et al.CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med, 2013; 19:1264–1272.
27.
HambardzumyanD, GutmannDH, KettenmannH. The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci, 2015; 19:20–27.
28.
LangenauDM, FengH, BerghmansS, KankiJP, KutokJL, LookAT. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA, 2005; 102:6068–6073.
29.
LangenauDM. Myc-induced T cell leukemia in transgenic zebrafish. Science, 2003; 299:887–890.
30.
SabaawyHE, AzumaM, EmbreeLJ, TsaiH-J, StarostMF, HicksteinDD. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA, 2006; 103:15166–15171.
31.
SantorielloC, DeflorianG, PezzimentiF, KawakamiK, LanfranconeL, d'Adda di FagagnaF, et al.Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells. Dis Model Mech, 2009; 2:56–67.
32.
SantorielloC, AnelliV, AlghisiE, MioneM. Highly penetrant melanoma in a zebrafish model is independent of ErbB3b signaling. Pigment Cell Melanoma Res, 2012; 25:287–289.
33.
ZengZ, RichardsonJ, VerduzcoD, MitchellDL, PattonEE. Zebrafish have a competent p53-dependent nucleotide excision repair pathway to resolve ultraviolet B-induced DNA damage in the skin. Zebrafish, 2009; 6:405–415.
34.
PattonEE, WidlundHR, KutokJL, KopaniKR, AmatrudaJF, MurpheyRD, et al.BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol, 2005; 15:249–254.
35.
JungIH, LeemGL, JungDE, KimMH, KimEY, KimSH, et al.Glioma is formed by active Akt1 alone and promoted by active Rac1 in transgenic zebrafish. Neuro Oncol, 2013; 15:290–304.
36.
ShinJ, PadmanabhanA, de GrohED, LeeJS, HaidarS, DahlbergS, et al.Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development. Dis Model Mech, 2012; 5:881–894.
37.
LalS, La DuJ, TanguayRL, GreenwoodJA. Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment. J Neurosci Res, 2011; 90:769–781.
38.
WelkerAM, JarosBD, PuduvalliVK, ImitolaJ, KaurB, BeattieCE. Standardized orthotopic xenografts in zebrafish reveal glioma cell line specific characteristics and tumor cell heterogeneity. Dis Model Mech, 2015; 9:1063–1065.
39.
RenshawSA, TredeNS. A model 450 million years in the making: zebrafish and vertebrate immunity. Dis Model Mech, 2011; 5:38–47.
40.
PaikEJ, ZonLI. Hematopoietic development in the zebrafish. Int J Dev Biol, 2010; 54:1127–1137.
41.
PalmerGM, FontanellaAN, ShanS, HannaG, ZhangG, FraserCL, et al.In vivo optical molecular imaging and analysis in mice using dorsal window chamber models appliedto hypoxia, vasculature and fluorescent reporters. Nat Protoc, 2011; 6:1355–1366.
42.
MaesW, Van GoolSW. Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model. Cancer Immunol Immunother, 2010; 60:153–160.
43.
ResendeFFB, BaiX, Del BelEA, KirchhoffF, SchellerA, Titze-de-AlmeidaR. Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction. BMC Cancer, 2016; 16:72.
44.
BayerlSH, NiesnerR, CseresnyesZ, RadbruchH, PohlanJ, BrandenburgS, et al.Time lapse in vivo microscopy reveals distinct dynamics of microglia-tumor environment interactions—a new role for the tumor perivascular space as highway for trafficking microglia. Glia, 2016; 64:1210–1226.
45.
RicardC, TchoghandjianA, LucheH, GrenotP, Figarella-BrangerD, RougonG, et al.Phenotypic dynamics of microglialand monocyte-derived cells inglioblastoma-bearing mice. Sci Rep, 2016; 6:1–15.
46.
EllettF, PaseL, HaymanJW, AndrianopoulosA, LieschkeGJ. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood, 2011; 117:e49–e56.
47.
ShiauCE, KaufmanZ, MeirelesAM, TalbotWS. Differential requirement for irf8 in formation of embryonic and adult macrophages in zebrafish. PLoS One, 2015; 10:e0117513.
48.
PeriF, Nüsslein-VolhardC. Live Imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell, 2008; 133:916–927.
49.
SvahnAJ, GraeberMB, EllettF, LieschkeGJ, RinkwitzS, BennettMR, et al.Development of ramified microglia from early macrophages in the zebrafish optic tectum. Dev Neurobiol, 2012; 73:60–71.
50.
LiY, DuX-F, LiuC-S, WenZ-L, DuJ-L. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Dev Cell, 2012; 23:1189–1202.
51.
RadaelliE, CerutiR, PattonV, RussoM, DegrassiA, CrociV, et al.Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease. Histol Histopathol, 2009; 24:879–891.
52.
JacobsVL, ValdesPA, HickeyWF, De LeoJA. Current review of in vivoGBM rodent models: emphasis on the CNS-1 tumour model. ASN Neuro, 2011; 3:171–181.
53.
CandolfiM, CurtinJF, NicholsWS, MuhammadAG, KingGD, PluharGE, et al.Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol, 2007; 85:133–148.
54.
GeigerGA, FuW, KaoGD. Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system. Cancer Res, 2008; 68:3396–3404.
55.
LallyBE, GeigerGA, KridelS, Arcury-QuandtAE, RobbinsME, KockND, et al.Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library. Cancer Res, 2007; 67:8791–8799.
56.
YangX-J, CuiW, GuA, XuC, YuS-C, LiT-T, et al.A novel zebrafish xenotransplantation model for study of glioma stem cell invasion. PLoS One, 2013; 8:e61801.
57.
KitambiSS, ToledoEM, UsoskinD, WeeS, HarisankarA, SvenssonR, et al.Vulnerability of glioblastoma cellsto catastrophic vacuolization and death induced by a small molecule. Cell, 2014; 157:313–328.
58.
HruzT, LauleO, SzaboG, WessendorpF, BleulerS, OertleL, et al.Genevestigator V3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinformatics, 2008; 2008:1–5.
59.
ChangY. Lymphotoxin β receptor induces interleukin 8 gene expression via NF-κB and AP-1 activation. Exp Cell Res, 2002; 278:166–174.
60.
SuwaraMI, GreenNJ, BorthwickLA, MannJ, Mayer-BarberKD, BarronL, et al.Released from damaged epithelial cells issufficient and essential to trigger inflammatory responses in human lung fibroblasts. Nature, 2013; 7:684–693.
61.
VerhaakRGW, HoadleyKA, PurdomE, WangV, QiY, WilkersonMD, et al.Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 2010; 17:98–110.
62.
DoucetteT, RaoG, RaoA, ShenL, AldapeK, WeiJ, et al.Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas. Cancer Immunol Res, 2013; 1:112–122.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
